Melinta是Cempra制药公司的继承实体。Cempra制药公司位于北卡罗来纳州教堂山市,于2005年11月18日成立,是一家开发抗细菌...查看全文
用户48783635432019-04-10 11:18
【4月9日医药股盘点】$Histogenics(HSGX)$$PhaseBio制药(PHAS)$ $Melinta Therapeutics(MLNT)$ 细胞疗法公司Histogenics同制药公司Ocugen合并,上涨56%;制药公司PhaseBio Pharmaceuticals上涨17.15%;抗生素开发公司Melinta Therapeutics上涨15.15%等。查看全文网页链接查看全文
$Melinta Therapeutics, Inc.(MLNT)$ 8-K/A [Amend] - Current report Filed: 2017-12-05 AccNo: 0001193125-17-361673 Size: 1 MBItem 9.01: Financial Statements and Exhibits 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-12-04 AccNo: 0001193125-17-359569 Size: 69 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2017-12-04 AccNo: 0001193125-17-359568 Size: 69 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-12-01 AccNo: 0001193125-17-358180 Size: 1 MB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2017-12-01 AccNo: 0001193125-17-358179 Size: 1 MBItem 1.01: Entry into a Material Definitive AgreementItem 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of...
$Melinta Therapeutics, Inc.(MLNT)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-11-29 AccNo: 0001193125-17-355854 Size: 57 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2017-11-29 AccNo: 0001193125-17-355852 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2017-11-29 AccNo: 0001193125-17-355847 Size: 174 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-11-29 AccNo: 0001193125-17-355854 Size: 57 KB 网页链接
$Melinta Therapeutics, Inc.(MLNT)$ 8-K - Current report Filed: 2017-11-29 AccNo: 0001193125-17-355852 Size: 57 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接